Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-11-19Acute HIV-1 Infection Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2013-11-15Enhancing Message Design in Tailored, Computerized HIV/STI Interventions
-
CLINICAL_TRIALS study record update · 2013-11-15Depression Treatment to Improve Antiretroviral Adherence
-
CLINICAL_TRIALS study record update · 2013-11-15International Trial of Modified Directly Observed Therapy Versus Self-Administered Therapy for Participants With First Virologic Failure on a Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Regimen
-
CLINICAL_TRIALS study record update · 2013-11-14Randomised, Double-blind, Placebo-controlled 7 Day Monotherapy Phase IIa Study to Evaluate the Antiviral Activity and Safety of Increasing Doses of Oral Administered RTV-boosted BILR 355 BS (75 mg and 150 mg Twice Daily) in HIV-1-infected, NNRTI-experienced Patients, Followed by 28 Day Combination Therapy With Tipranavir or Lopinavir Based HAART-regimen
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-11-13Immunologic Determinants of Hepatitis C Virus Infection Resolution or Persistence
-
CLINICAL_TRIALS study record update · 2013-11-11Pharmacokinetics of an Indinavir, Ritonavir and Amprenavir Regimen in HIV-Infected Individuals: A Pilot Study
-
CLINICAL_TRIALS study record update · 2013-11-08Valganciclovir to Reduce T Cell Activation in HIV Infection
-
CLINICAL_TRIALS study record update · 2013-11-06An Open-label Randomised Two-year Trial Comparing Two First-line Regimens in HIV-infected Antiretroviral naïve Subjects: Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir (ANRS 143/NEAT 001)
-
CLINICAL_TRIALS study record update · 2013-11-05An Open Label Safety Study of Tipranavir Co-Administered With Low-Dose Ritonavir (TVP/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
-
CLINICAL_TRIALS study record update · 2013-11-04NIMH Collaborative HIV/STD Prevention Trial
-
CLINICAL_TRIALS study record update · 2013-11-01A Randomised, Open Label, Active Controlled Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir Plus 100 mg or 200 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Comparison to 400 mg Lopinavir Plus 100 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Antiretroviral Therapy Naive Patients for 48 With Extension up to 156 Weeks
-
CLINICAL_TRIALS study record update · 2013-11-01An Open, Randomised, Multicentre, Comparative Trial, to Evaluate the Benefit of Switching From a PI-based Regimen to a Nevirapine-based Regimen on the Quality of Life, Patient Adherence, Patient's Perception of Fat Redistribution and Metabolic Changes, in HIV+ Patients Suffering From Fat Abnormalities
-
CLINICAL_TRIALS study record update · 2013-10-31A Randomised Open Label Multi-centre Trial to Evaluate the Pharmacokinetic, Efficacy and Safety Parameters of Nevirapine 150mg/m2 and Nevirapine 4 or 7 mg/kg When Administered in Combination With AZT and 3TC for 48 Weeks in Antiretroviral naïve Paediatric Patients.
-
CLINICAL_TRIALS study record update · 2013-10-28Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy in HIV-infected Women
-
CLINICAL_TRIALS study record update · 2013-10-24A Clinical Trial to Establish The Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
-
CLINICAL_TRIALS study record update · 2013-10-22A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir: A 24-hour Pharmacokinetic Profile to Evaluate Sex Differences
-
CLINICAL_TRIALS study record update · 2013-10-22A Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Recombinant Human Growth Hormone (Serostim) in the Treatment of HIV-Associated Catabolism/Wasting
-
CLINICAL_TRIALS study record update · 2013-10-22A Pilot Study to Assess the Safety, Efficacy, and PK Profile of a Switch in Antiretroviral Therapy to a RTI Sparing Combination of LPV/r and RAL in Virologically Suppressed HIV-infected Patients
-
CLINICAL_TRIALS study record update · 2013-10-17"PIQD: The Once a Day Protease Inhibitor Regimens." Ritonavir Boosted Atazanavir vs. Ritonavir Boosted Fosamprenavir Used in Combination With Tenofovir and Emtricitabine in HIV-1 Infected Antiretroviral Treatment-Naïve Patients.
-
CLINICAL_TRIALS study record update · 2013-10-17Treatment of Acute Hepatitis C Virus in HIV Co-Infection
-
CLINICAL_TRIALS study record update · 2013-10-17A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
-
CLINICAL_TRIALS study record update · 2013-10-11Interactions Between HIV and Malaria in African Children
-
CLINICAL_TRIALS study record update · 2013-10-10A Phase 2a, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C
-
CLINICAL_TRIALS study record update · 2013-10-08Phase I of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe